Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawei Wu

Showing results (241-250 of 247) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 247 results.
BMJ Open|June 4, 2021
Platform study of genotyping-guided precision medicine for rare solid tumours: a study protocol for a phase II, non-randomised, 18-month, open-label, multiarm, single-centre clinical trial testing the safety and efficacy of multiple Chinese-approved targeted drugs and PD-1 inhibitors in the treatment of metastatic rare tumoursShuhang Wang, Hui-Yao Huang, Dawei Wu, et al.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|May 10, 2020
[Stratified outcomes of "Kidney Disease: Improving Global Outcomes" serum creatinine criteria in critical ill patients: a secondary analysis of a multicenter prospective study]Guiying Dong, Junping Qin, Youzhong An, et al.
Renal Failure|December 3, 2021
Utilizing reclassification to explore characteristics and prognosis of KDIGO<sub>SCr</sub> AKI subgroups: a retrospective analysis of a multicenter prospective cohort studyGui-Ying Dong, Jun-Ping Qin, Youzhong An, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2020
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLCShugeng Gao, Ning Li, Shunyu Gao, et al.
The Lancet Regional Health. Western Pacific|November 25, 2022
The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challengesHuiyao Huang, Yu Tang, Yue Yu, et al.
Critical Care Medicine|June 5, 2019
XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled TrialYuanlin Song, Chen Yao, Yongming Yao, et al.
JAMA Internal Medicine|May 1, 2023
Effect of an Herbal-Based Injection on 28-Day Mortality in Patients With Sepsis: The EXIT-SEP Randomized Clinical TrialSongqiao Liu, Chen Yao, Jianfeng Xie, et al.
Pageof 25

Showing results (241-250 of 247) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 247 results.
BMJ Open|June 4, 2021
Platform study of genotyping-guided precision medicine for rare solid tumours: a study protocol for a phase II, non-randomised, 18-month, open-label, multiarm, single-centre clinical trial testing the safety and efficacy of multiple Chinese-approved targeted drugs and PD-1 inhibitors in the treatment of metastatic rare tumoursShuhang Wang, Hui-Yao Huang, Dawei Wu, et al.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|May 10, 2020
[Stratified outcomes of "Kidney Disease: Improving Global Outcomes" serum creatinine criteria in critical ill patients: a secondary analysis of a multicenter prospective study]Guiying Dong, Junping Qin, Youzhong An, et al.
Renal Failure|December 3, 2021
Utilizing reclassification to explore characteristics and prognosis of KDIGO<sub>SCr</sub> AKI subgroups: a retrospective analysis of a multicenter prospective cohort studyGui-Ying Dong, Jun-Ping Qin, Youzhong An, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2020
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLCShugeng Gao, Ning Li, Shunyu Gao, et al.
The Lancet Regional Health. Western Pacific|November 25, 2022
The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challengesHuiyao Huang, Yu Tang, Yue Yu, et al.
Critical Care Medicine|June 5, 2019
XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled TrialYuanlin Song, Chen Yao, Yongming Yao, et al.
JAMA Internal Medicine|May 1, 2023
Effect of an Herbal-Based Injection on 28-Day Mortality in Patients With Sepsis: The EXIT-SEP Randomized Clinical TrialSongqiao Liu, Chen Yao, Jianfeng Xie, et al.
Pageof 25